Coenzyme Q10 showed no clear difference in myocardial infarction compared with placebo or conventional therapy (low certainty).
Alirocumab showed no clear difference in myocardial infarction compared with ezetimibe and statins (low certainty).
It is very uncertain whether evolocumab changes myocardial infarction compared with ezetimibe and statins (very low certainty).
Alirocumab leads to lower myocardial infarction compared with placebo (high certainty).
Evolocumab leads to lower myocardial infarction compared with placebo (high certainty).
Mediterranean dietary intervention showed no clear difference in myocardial infarction compared with another dietary intervention (low certainty).
Transcatheter aortic valve implantation showed no clear difference in myocardial infarction compared with surgical aortic valve replacement (moderate certainty).
Homocysteine‐lowering interventions (Vitamin B6 (pyridoxine;… showed no clear difference in myocardial infarction compared with placebo or standard care (high certainty).
Homocysteine‐lowering interventions (high dose) showed no clear difference in myocardial infarction compared with homocysteine‐lowering interventions (low dose) (moderate certainty).
Enalapril plus folic acid showed no clear difference in myocardial infarction compared with enalapril (moderate certainty).
Routine invasive strategies showed no clear difference in myocardial infarction compared with selective invasive strategies (conservative) (moderate certainty).
It is very uncertain whether effect of reducing saturated fat changes myocardial infarctions compared with usual saturated fat on CVD risk (very low certainty).
Colchicine probably leads to lower myocardial Infarction (total) compared with any control treatment (moderate certainty).
Antibiotics showed no clear difference in myocardial infarction at 24±6 months compared with placebo or no intervention (moderate certainty).
The intervention probably leads to lower myocardial infarction at maximum (moderate certainty).
Beta‐blockers showed no clear difference in myocardial infarction at maximum compared with placebo or no intervention (low certainty).
It is very uncertain whether drug‐eluting stents changes myocardial infarction at maximum compared with bare‐metal stents (very low certainty).
The intervention probably leads to lower myocardial infarction (non‐fatal) (moderate certainty).
It is very uncertain whether exercise‐based cardiac rehabilitation changes acute myocardial infarction (AMI) compared with usual care (very low certainty).
It is very uncertain whether summary of findings table ‐ Pharmacological treatment changes myocardial infarction ‐ short term compared with placebo (very low certainty).